Systematic review of health-related quality of life (HRQoL) issues associated with gastric cancer: capturing cross-cultural differences Alison RowsellSamantha C. SodergrenMitsumi Terada Review Article Open access 11 June 2022 Pages: 665 - 677
Tumorigenic mechanisms of estrogen and Helicobacter pylori cytotoxin-associated gene A in estrogen receptor α-positive diffuse-type gastric adenocarcinoma Seungkyung KangMiree ParkSoo-Jeong Cho Original Article 07 April 2022 Pages: 678 - 696
Clinicopathologic and genomic characteristics of mucinous gastric adenocarcinoma Jae Eun LeeYoon Young ChoiJae-Ho Cheong Original Article 09 May 2022 Pages: 697 - 711
Removal of small extracellular vesicles inhibits the progression of peritoneal dissemination in gastric cancer Jun ShibamotoTomohiro AritaEigo Otsuji Original Article 04 April 2022 Pages: 712 - 725
Ubiquitination of ADRα1d/SerpinA1 complex stimulates hypoxia to induce gastric tumorigenesis with a combination of Helicobacter pylori and chronic stress through IL-1α Faisal AzizXiang LiZigang Dong Original Article 07 May 2022 Pages: 726 - 740
Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapy Joe YeongHuey Yew Jeffrey LumRaghav Sundar Original Article Open access 04 June 2022 Pages: 741 - 750
Deep learning for automatic diagnosis of gastric dysplasia using whole-slide histopathology images in endoscopic specimens Zhongyue ShiChuang ZhuMulan Jin Original Article 08 April 2022 Pages: 751 - 760
A comparative study of demarcation line diagnostic performance between non-magnifying observation with white light and non-magnifying observation with narrow-band light for early gastric cancer Toshiki KojimaKenshi YaoAkinori Iwashita Original Article 06 May 2022 Pages: 761 - 769
Evaluation of clinical validity of an S-1 dosage formula based on renal function using data of the SPIRITS and the G-SOX trials Eisuke BookaChiyo K. ImamuraNarikazu Boku Original Article 31 March 2022 Pages: 770 - 782
A randomized phase III study of fractionated docetaxel, oxaliplatin, capecitabine (low-tox) vs epirubicin, oxaliplatin and capecitabine (eox) in patients with locally advanced unresectable or metastatic gastric cancer: the lega trial Gerardo RosatiChiara Alessandra CellaRoberto Labianca Original Article 30 March 2022 Pages: 783 - 793
Association between HER2 heterogeneity and clinical outcomes of HER2-positive gastric cancer patients treated with trastuzumab Kyunghye BangJaekyung CheonYoon-Koo Kang Original Article 07 May 2022 Pages: 794 - 803
Clinical advantage of standardized robotic total gastrectomy for gastric cancer: a single-center retrospective cohort study using propensity-score matching analysis Susumu ShibasakiMasaya NakauchiKoichi Suda Original Article 17 March 2022 Pages: 804 - 816
Safety assessment of robotic gastrectomy and analysis of surgical learning process: a multicenter cohort study Norihiro ShimoikeTatsuto Nishigorion behalf of Kyoto Esophageal and Gastric Surgery Study Group Original Article 13 April 2022 Pages: 817 - 826
Application value of overlap guiding tube (OGT) in assisting overlap esophagojejunostomy during laparoscopic total gastrectomy for gastric/gastroesophageal junction (G/GEJ) tumors Chen XinhuaLin TianYu Jiang Original Article Open access 23 April 2022 Pages: 827 - 836